447
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

G71R mutation of the UGT1A1 gene is not associated with neonatal hyperbilirubinemia in India

, , &
Pages 1833-1834 | Received 09 Sep 2011, Accepted 17 Nov 2011, Published online: 04 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hassan Mehrad-Majd, Monir Sadat Haerian, Javad Akhtari, Yalda Ravanshad, Anoush Azarfar & Gholamali Mamouri. (2019) Effects of Gly71Arg mutation in UGT1A1 gene on neonatal hyperbilirubinemia: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 32:10, pages 1575-1585.
Read now

Articles from other publishers (3)

Jing Wang, Jiansong Yin, Mei Xue, Jun Lyu & Yu Wan. (2020) Roles of UGT1A1 Gly71Arg and TATA promoter polymorphisms in neonatal hyperbilirubinemia: A meta-analysis. Gene 736, pages 144409.
Crossref
Ashish S. Chiddarwar, Selma Z. D'Silva, Roshan B. Colah, Kanjaksha Ghosh & Malay B. Mukherjee. (2017) Genetic Variations in Bilirubin Metabolism Genes and Their Association with Unconjugated Hyperbilirubinemia in Adults. Annals of Human Genetics 81:1, pages 11-19.
Crossref
Zibi YuKaichang ZhuLi WangYing LiuJianmei Sun. (2015) Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis. Medical Science Monitor 21, pages 3104-3114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.